Alivation Research, LLC.

Lincoln, Nebraska 68526-9467

5 studies enrolling now · 34 studies all time

What they study most

ADHD, Acute Treatment of Migraine, Alzheimer's Disease Psychosis, Apnea, Apnea+Hypopnea, Apnea, Obstructive, Apnea, Obstructive Sleep, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD)

Studies at this site

• ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response — Recruiting now
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients — Recruiting now
• Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients — Recruiting now
• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder — Recruiting now
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression — Recruiting now
• Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder — Completed
• Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation — Completed
• RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS — Running, not enrolling
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD — Completed
• A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD — Running, not enrolling
• Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD — Running, not enrolling
• Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD — Stopped early
• A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD — Completed
• An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD — Completed
• A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression). — Stopped early
• A Study of JZP150 in Adults With Posttraumatic Stress Disorder — Completed
• The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes — Stopped early
• A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder. — Stopped early
• Guided ADHD Therapy for Managing the Extent and Severity of Symptoms — Completed
• Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD — Completed
• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment — Stopped early
• Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD) — Completed
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) — Completed
• Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension — Completed
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
• A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® — Stopped early
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) — Stopped early